Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma

Figure 2 Images in a 73-year-old woman with a solitary hepatocellular carcinoma (tumor size 2. 6 cm) in segment VI. A and B: Axial view of T2- and T1-weighted magnetic resonance images with fat suppression before administration of gadolinium ethoxybenzyl diethylene-triaminepentaacetic acid; C: Arterial phase and D: Portal venous phase showing hyperenhancing mass in segment VI with washout appearance, which is the typical appearance of hepatocellular carcinoma, as well as corona enhancement (arrow); E: Hepatobiliary phase, axial view of T1-weighted three-dimensional gradient-echo magnetic resonance image with fat suppression. The faint low signal intensity around the tumor is the peritumoral hypointensity (arrow); F: The tumor is identifiable postoperatively as a pT2 hepatocellular carcinoma because a satellite nodule surrounds the main tumor.